Grethel Artavia and her son Alexey. Photo courtesy of Azul Films
Grethel Artavia and her son Alexey. Photo courtesy of Azul Films

QCOSTARICA -As the only country in the world to outlaw in vitro fertilization treatment, Costa Ricans will be – for the first time in 15 years – presented with the possibility of having fertility treatments, according to an executive decree signed Thursday by President, Luis Guillermo Solis.

This move comes amidst bitter opposition from the Catholic Church, court battles and hearings that spanned years, increased pressure from human rights organizations and a national debate about reproductive rights that divided much of the country.

That struggle is captured by journalist Gabriela Quiros in her timely documentary, Beautiful Sin.

 

Andrea Bianchi and her husband Alberto Moreno, and their children Camila and Alejandro, are one of the three families the documentary ‘Beautiful Sin’ follows for a decade. Bianchi and Moreno were one of several couples who took the Costa Rican government before an international human rights court to fight that country’s ban on in vitro fertilization (IVF), a fertility treatment in which doctors create embryos in the lab. Costa Rica is the only country in the world that has outlawed IVF. The country lifted its 15-year-old ban on Sept. 10, 2015. Photo courtesy of Azul Films.
Andrea Bianchi and her husband Alberto Moreno, and their children Camila and Alejandro, are one of the three families the documentary ‘Beautiful Sin’ follows for a decade. Bianchi and Moreno were one of several couples who took the Costa Rican government before an international human rights court to fight that country’s ban on in vitro fertilization (IVF), a fertility treatment in which doctors create embryos in the lab. Costa Rica is the only country in the world that has outlawed IVF. The country lifted its 15-year-old ban on Sept. 10, 2015. Photo courtesy of Azul Films.

Click here for the Mission Local report – Filmmaker Chronicles Ban on Fertility Treatment


Stay up to date with the latest stories by signing up to our newsletter, or following us on Facebook.